Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Antidiabetics”

183 trials

Showing 20 of 183 results

Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Post-approval studies (Phase 4)Study completedNCT03269058
What this trial is testing

Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes

Who this might be right for
Type-2 DiabetesOral Antidiabetics
Centre Hospitalier Universitaire Dijon 28
Not applicableStudy completedNCT01281605
What this trial is testing

Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Mackay Memorial Hospital 181
Not applicableStudy completedNCT04813146
What this trial is testing

Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics

Who this might be right for
Diabetic Neuropathies
Riphah International University 216
Large-scale testing (Phase 3)Study completedNCT01029886
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 912
Post-approval studies (Phase 4)Study completedNCT00548808
What this trial is testing

Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 426
Large-scale testing (Phase 3)Study completedNCT00434954
What this trial is testing

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 494
Large-scale testing (Phase 3)Study completedNCT00174642
What this trial is testing

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 811
Testing effectiveness (Phase 2)Looking for participantsNCT07239011
What this trial is testing

Dapagliflozin in Depression

Who this might be right for
Depression
Tanta University 60
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162
Testing effectiveness (Phase 2)Study completedNCT01511198
What this trial is testing

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 223
Large-scale testing (Phase 3)Study completedNCT01513590
What this trial is testing

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Not applicableStudy completedNCT00865397
What this trial is testing

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,032
Post-approval studies (Phase 4)Study completedNCT00708578
What this trial is testing

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 99
Post-approval studies (Phase 4)Looking for participantsNCT06613854
What this trial is testing

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana 90
Large-scale testing (Phase 3)WithdrawnNCT07057479
What this trial is testing

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
Not applicableStudy completedNCT00825643
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 18,481
Not applicableUnknownNCT04958980
What this trial is testing

Multiprofessional Approach in Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Leonardo Paroche de Matos 24
Large-scale testing (Phase 3)Study completedNCT00603291
What this trial is testing

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

Who this might be right for
Obesity
Eisai Inc. 604
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation